SCHEMBL29519729

SCHEMBL29519729

N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.54
▸ MC4R P32245 1/20 0.52
▸ F2 P00734 4/20 0.52
▸ CTSL P07711 3/20 0.52
▸ CTSS P25774 3/20 0.52
▸ CTSK P43235 3/20 0.52
▸ CTSH P09668 1/20 0.52
▸ APLNR P35414 1/20 0.51
▸ EPHA2 P29317 2/20 0.49
▸ NTSR2 O95665 1/20 0.49
▸ NTSR1 P30989 1/20 0.49
▸ SORT1 Q99523 1/20 0.49
▸ RAMP3 O60896 1/20 0.49
▸ CALCR P30988 1/20 0.49
▸ OPRM1 P35372 1/20 0.48
▸ NPFFR1 Q9GZQ6 1/20 0.48
▸ NPFFR2 Q9Y5X5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31096802 0.92 C5AR1 (0.53) C5AR1CTSLCTSSCTSKCTSH
SCHEMBL30547344 0.92 EPHA2 (0.55) C5AR1F2CTSLCTSSCTSK
SCHEMBL30208250 0.88 EPHA2 (0.56) C5AR1MC4RF2CTSLCTSS
SCHEMBL30948380 0.88 APLNR (0.52) C5AR1F2CTSLCTSSCTSK
SCHEMBL29641118 0.88 C5AR1 (0.60) C5AR1MC4RF2APLNREPHA2
SCHEMBL29641093 0.87 C5AR1 (0.64) C5AR1MC4RF2APLNROPRM1
SCHEMBL30997477 0.87 F2 (0.52) C5AR1F2CTSLCTSSCTSK
SCHEMBL30255096 0.86 NMUR2 (0.57) C5AR1MC4RF2CTSLCTSS
SCHEMBL30811617 0.86 C5AR1 (0.57) C5AR1APLNREPHA2NTSR2NTSR1
SCHEMBL32664435 0.86 NTSR2 (0.58) NTSR2NTSR1SORT1OPRM1NPFFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124612-A1 MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES MEDIMMUNE LLC 2024-04-18 — — US disclosed
US-11767369-B2 Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties MEDIMMUNE, LLC (US) 2023-09-26 — — US disclosed
CN-106413750-B Molecules with altered neonatal Fc receptor binding with enhanced therapeutic and diagnostic properties 免疫医疗有限责任公司 2022-04-29 — — CN disclosed
Send feedback